Illinois Wesleyan University alumnus Charles Hawker has received the Outstanding Lifetime
Achievement Award in Clinical Chemistry and Laboratory Medicine from the American
Association for Clinical Chemistry (AACC). Hawker is scientific director of automation
and special projects for ARUP Laboratories in Salt Lake City.
His work investigating and developing several automation and robotic systems has made
ARUP a national leader in productivity and quality and one of the most automated clinical
laboratories in North America.
Hawker developed one of the first widely used radioimmunoassays for parathyroid hormone
in 1971. He also published the first reports about a peptide known as procalcitonin
that, when elevated, can be a marker of septic shock. Hawker holds three patents and
has published 43 peer-reviewed papers, 14 book chapters or invited reviews, and 47
abstracts. A frequent lecturer at national and international conferences, Hawker is
also an adjunct professor of pathology at the University of Utah’s School of Medicine.
Hawker previously received the John V. Bergen award from the Clinical and Laboratory
Standards Institute, the Professor Alvin Dubin award from the National Academy of
Clinical Biochemistry (NACB), the Diploma of Honor from the Association of Clinical
Scientists (ACS) and the Becton Dickinson award from the Association for Laboratory
Automation. He has served as president of NACB, ACS and the Clinical Ligand Assay
After majoring in chemistry from Illinois Wesleyan, Hawker earned a Ph.D. in biochemistry from the University
of Pennsylvania and an M.B.A. from Washington University in St. Louis.
Considered the premier award of the AACC, the Outstanding Lifetime Achievement Award
in Clinical Chemistry and Laboratory Medicine is awarded to an individual that has
made significant contributions in all aspects of clinical chemistry, achieved international
reputation and demonstrated long-standing service to the association.